Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide effects on reward mechanisms in obesity
NCT03347890Phase 4Completed
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity. Started Mar 2018; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03347890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347890.